The Potential of Integrin alphavbeta5 receptor as A Drug Target

Target Name: Integrin alphavbeta5 receptor

NCBI ID: P5756

Integrin alphavbeta5 receptor

Other Name(s): alphavbeta5

The Potential of Integrin alphavbeta5 receptor as A Drug Target

The Integrin alphavbeta5 receptor (alphavbeta5) is a protein that is expressed in many different tissues throughout the body. It is a member of the integrin alpha-尾 chain, which is a family of transmembrane proteins that play a role in cell-cell adhesion, migration, and other cellular processes.

伪v尾5 is a 20-kDa cell surface protein that is involved in many different cellular processes, including cell adhesion, migration, and the regulation of cell cycle progression. It is a critical regulator of cell-cell adhesion, allowing cells to stick together and form tissues. It is also involved in the regulation of cell growth, cell cycle progression, and apoptosis.

One of the most promising aspects of 伪v尾5 is its potential as a drug target. Several studies have suggested that inhibiting 伪v尾5 may be a effective way to treat a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key reasons for the potential of 伪v尾5 as a drug target is its involvement in many different cellular processes that are often disrupted in diseases. For example, 伪v尾5 is involved in cell-cell adhesion, which is often disrupted in many diseases, including cancer. By inhibiting 伪v尾5, researchers may be able to encourage cells to detach and migrate, which could be a useful therapeutic approach for treating many diseases.

伪v尾5 is also involved in the regulation of cell cycle progression, which is often disrupted in many diseases, including cancer. By inhibiting 伪v尾5, researchers may be able to inhibit the growth and proliferation of cancer cells. This could be a useful approach for treating many types of cancer.

In addition to its involvement in cellular processes, 伪v尾5 is also involved in the regulation of apoptosis, which is the process by which cells undergo programmed cell death. This is important for maintaining the homeostasis of the body, and is often disrupted in many diseases, including neurodegenerative diseases. By inhibiting 伪v尾5, researchers may be able to encourage the programmed cell death that is necessary for maintaining the health and function of the body.

Overall, the Integrin alpha-v尾5 receptor is a protein that is involved in many different cellular processes that are often disrupted in diseases. As a result, it is a promising target for drug development. Further research is needed to fully understand the role of 伪v尾5 in cellular processes and its potential as a drug target.

Protein Name: Integrin Alphavbeta5 Receptor

The "Integrin alphavbeta5 receptor Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Integrin alphavbeta5 receptor comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets